ClinicalTrials.govpublic full text
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
epstein-barr virus infections, lymphoma, lymphoproliferative disorder, disorders, lymphoproliferative, monoclonal antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 844338
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.